Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal drug delivery systems versus comprehensive medical management for severe cancer pain
2025-522381-68-00Phase 4Authorised
- Sponsor
- Vrije Universiteit Brussel
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of morphine hydrochloride in cancer pain (2 arms), sponsored by Vrije Universiteit Brussel. Primary endpoint: Health-related quality of life (HRQoL). Planned start Mar 2026; status: authorised.
02
Drugs
morphine hydrochloride
03
Conditions
cancer pain
Beyond the preview
Go deeper on 2025-522381-68-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-522381-68-00.